Type1diabetes
Metabolic Diseases
1
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
T-TherapeuticsUK - Cambridge
1 program1
Stem cells from human exfoliated teethPhase 11 trial
Active Trials
Novo NordiskBAGSVAERD DENMARK, Denmark
1 programInfusion of GIP[1-42], GIP[1-30] or placeboN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
T-TherapeuticsStem cells from human exfoliated teeth
Novo NordiskInfusion of GIP[1-42], GIP[1-30] or placebo
DiabeloopDBLG1 System
Clinical Trials (3)
Total enrollment: 10 patients across 3 trials
Stem Cells From Human Exfoliated Teeth in Treatment of Diabetic Patients With Significantly Reduced Islet Function
Start: Jan 2019Est. completion: Mar 2021
Phase 1Unknown
The Effect of Glucose-dependent Insulinotropic Polypeptide on the Alpha Cell Response to Hypoglycaemia in Patients with Type 1 Diabetes
Start: Aug 2022Est. completion: May 202410 patients
N/ACompleted
Observational Study of the Use of DBLG1 System in Real Life
Start: May 2021Est. completion: Jan 2026
N/ARecruiting
Related Jobs in Metabolic Diseases
Manager, Patient Safety and Pharmacovigilance Operations
Kailera Therapeutics
Waltham, Massachusetts
7h ago
Senior Medical Science Liaison - Obesity - Northern CA, Central CA, NV
Amgen
California - San Francisco, US
Yesterday
(Sr) Scientist Analytical Chemistry – Mass Spectrometry (Temporary role 3 years)
Johnson & Johnson
Beerse, Antwerp, Belgium
2d ago
Computational Chemist
Topos Bio
San Francisco Office
2d ago
Associate Director, Legal Operations & Contracts Management
Kailera Therapeutics
Massachusetts
4d ago
From $155K/yr
Team Lead Manufacturing (m/w/d) Blutzuckermonitoring (BGM) und Point-of-Care (POC) Produkte - befristet
Roche
Mannheim
5d ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 10 patients
3 companies competing in this space